VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 94 filers reported holding VERONA PHARMA PLC in Q1 2023. The put-call ratio across all filers is 1.24 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $61,577,781 | -22.9% | 3,777,778 | 0.0% | 1.31% | -9.6% |
Q2 2023 | $79,862,227 | -6.7% | 3,777,778 | -11.3% | 1.45% | -13.9% |
Q1 2023 | $85,554,675 | -28.4% | 4,260,691 | -6.8% | 1.68% | -26.5% |
Q4 2022 | $119,473,912 | +105.3% | 4,572,289 | -19.7% | 2.29% | +111.7% |
Q3 2022 | $58,201,000 | +143.9% | 5,694,841 | 0.0% | 1.08% | +150.0% |
Q2 2022 | $23,861,000 | -16.0% | 5,694,841 | 0.0% | 0.43% | -6.3% |
Q1 2022 | $28,417,000 | -25.7% | 5,694,841 | 0.0% | 0.46% | -6.3% |
Q4 2021 | $38,269,000 | +22.6% | 5,694,841 | 0.0% | 0.49% | +43.4% |
Q3 2021 | $31,208,000 | -16.2% | 5,694,841 | 0.0% | 0.34% | -9.0% |
Q2 2021 | $37,244,000 | -21.8% | 5,694,841 | 0.0% | 0.38% | -15.3% |
Q1 2021 | $47,609,000 | +19.4% | 5,694,841 | 0.0% | 0.44% | +27.5% |
Q4 2020 | $39,864,000 | +12.2% | 5,694,841 | 0.0% | 0.35% | -21.9% |
Q3 2020 | $35,536,000 | +507.2% | 5,694,841 | +355.4% | 0.45% | +445.1% |
Q2 2020 | $5,852,000 | +13.6% | 1,250,396 | 0.0% | 0.08% | -5.7% |
Q1 2020 | $5,152,000 | -28.3% | 1,250,396 | 0.0% | 0.09% | -15.5% |
Q4 2019 | $7,190,000 | +25.8% | 1,250,396 | 0.0% | 0.10% | -4.6% |
Q3 2019 | $5,714,000 | -10.4% | 1,250,396 | 0.0% | 0.11% | +9.1% |
Q2 2019 | $6,377,000 | -21.5% | 1,250,396 | 0.0% | 0.10% | -21.4% |
Q1 2019 | $8,128,000 | -32.6% | 1,250,396 | 0.0% | 0.13% | -43.5% |
Q4 2018 | $12,066,000 | -22.9% | 1,250,396 | 0.0% | 0.22% | +18.6% |
Q3 2018 | $15,642,000 | -8.4% | 1,250,396 | 0.0% | 0.19% | -7.8% |
Q2 2018 | $17,080,000 | -31.7% | 1,250,396 | 0.0% | 0.20% | -34.2% |
Q1 2018 | $25,008,000 | +68.5% | 1,250,396 | 0.0% | 0.31% | +64.9% |
Q4 2017 | $14,843,000 | +45.1% | 1,250,396 | +87.6% | 0.19% | +91.8% |
Q3 2017 | $10,233,000 | +31.7% | 666,666 | 0.0% | 0.10% | +21.0% |
Q2 2017 | $7,770,000 | – | 666,666 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 4,249,918 | $69,273,663 | 7.59% |
Aisling Capital Management LP | 1,115,352 | $18,180,238 | 7.49% |
NEA Management Company, LLC | 5,108,563 | $91,031,474 | 7.03% |
Octagon Capital Advisors LP | 2,369,000 | $38,614,700 | 5.93% |
Knoll Capital Management, LLC | 200,000 | $3,260,000 | 3.38% |
Frazier Life Sciences Management, L.P. | 3,014,349 | $49,133,889 | 3.26% |
Perceptive Advisors | 4,007,197 | $65,317,311 | 2.18% |
RA Capital Management | 6,317,990 | $102,983,237 | 2.03% |
Deep Track Capital, LP | 3,187,415 | $51,954,865 | 2.00% |
Carlyle Group Inc. | 2,457,500 | $40,008,100 | 1.74% |